Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

The paradox of high availability and low recognition of soluble HLA-G by LILRB1 receptor in rheumatoid arthritis patients.

Veit TD, Chies JA, Switala M, Wagner B, Horn PA, Busatto M, Brenol CV, Tavares Brenol JC, Machado Xavier R, Rebmann V.

PLoS One. 2015 Apr 8;10(4):e0123838. doi: 10.1371/journal.pone.0123838. eCollection 2015.

2.

HLA-G may predict the disease course in patients with early rheumatoid arthritis.

Rizzo R, Farina I, Bortolotti D, Galuppi E, Rotola A, Melchiorri L, Ciancio G, Di Luca D, Govoni M.

Hum Immunol. 2013 Apr;74(4):425-32. doi: 10.1016/j.humimm.2012.11.024. Epub 2012 Dec 8.

PMID:
23228398
3.

Soluble HLA-G in rheumatoid arthritis.

Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H.

Hum Immunol. 2006 Aug;67(8):561-7. Epub 2006 May 5.

PMID:
16916651
4.

Soluble HLA-DR levels in serum are associated with therapy and genetic factors in rheumatoid arthritis.

Verbruggen LA, Versaen H, Rebmann V, Duquet W, De Cock S, Grosse-Wilde H, Demanet C.

Hum Immunol. 2002 Sep;63(9):758-64.

PMID:
12175730
5.

HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.

Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M, Carturan S, Ferretti S, Trotta F, Baricordi OR.

Pharmacogenet Genomics. 2006 Sep;16(9):615-23.

PMID:
16906016
6.

The dimeric form of HLA-G molecule is associated with the response of early rheumatoid arthritis (ERA) patients to methotrexate.

Rizzo R, Farina I, Bortolotti D, Galuppi E, Padovan M, Di Luca D, Govoni M.

Clin Rheumatol. 2017 Mar;36(3):701-705. doi: 10.1007/s10067-016-3454-z. Epub 2016 Oct 24.

PMID:
27778096
7.

Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes.

Verbruggen LA, Dumarey N, Van de Velde H, Rebmann V, Flament J, Van Wayenberge C, Grosse-Wilde H, Demanet C.

Tissue Antigens. 2000 Nov;56(5):436-40.

PMID:
11144291
8.

Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis.

Kuroki K, Tsuchiya N, Shiroishi M, Rasubala L, Yamashita Y, Matsuta K, Fukazawa T, Kusaoi M, Murakami Y, Takiguchi M, Juji T, Hashimoto H, Kohda D, Maenaka K, Tokunaga K.

Hum Mol Genet. 2005 Aug 15;14(16):2469-80. Epub 2005 Jul 13.

PMID:
16014635
9.

Human leukocyte antigen-G polymorphism influences the age of onset and autoantibody status in rheumatoid arthritis.

Mariaselvam CM, Chaaben AB, Salah S, Charron D, Krishnamoorthy R, Tamouza R, Negi VS.

Tissue Antigens. 2015 Mar;85(3):182-9. doi: 10.1111/tan.12521. Epub 2015 Feb 6.

PMID:
25656292
10.

Genetic polymorphisms and expression of HLA-G and its receptors, KIR2DL4 and LILRB1, in non-small cell lung cancer.

Wiśniewski A, Kowal A, Wyrodek E, Nowak I, Majorczyk E, Wagner M, Pawlak-Adamska E, Jankowska R, Ślesak B, Frydecka I, Kuśnierczyk P.

Tissue Antigens. 2015 Jun;85(6):466-75. doi: 10.1111/tan.12561. Epub 2015 Apr 9.

PMID:
25855135
11.

HLA-G and HLA-E in patients with juvenile idiopathic arthritis.

Prigione I, Penco F, Martini A, Gattorno M, Pistoia V, Morandi F.

Rheumatology (Oxford). 2011 May;50(5):966-72. doi: 10.1093/rheumatology/keq418. Epub 2010 Dec 23.

PMID:
21186170
12.

Soluble human leukocyte antigen-g and its insertion/deletion polymorphism in papillary thyroid carcinoma: novel potential biomarkers of disease?

Dardano A, Rizzo R, Polini A, Stignani M, Tognini S, Pasqualetti G, Ursino S, Colato C, Ferdeghini M, Baricordi OR, Monzani F.

J Clin Endocrinol Metab. 2012 Nov;97(11):4080-6. doi: 10.1210/jc.2012-2231. Epub 2012 Aug 28.

PMID:
22930786
13.

Association between sHLA-G and HLA-G 14-bp deletion/insertion polymorphism in Crohn's disease.

Zidi I, Ben Yahia H, Bortolotti D, Mouelhi L, Laaribi AB, Ayadi S, Zidi N, Houissa F, Debbech R, Boudabous A, Najjar T, Di Luca D, Rizzo R.

Int Immunol. 2015 Jun;27(6):289-96. doi: 10.1093/intimm/dxv002. Epub 2015 Jan 10.

PMID:
25577194
14.

Increased plasmatic soluble HLA-G levels in endometrial cancer.

Ben Yahia H, Babay W, Bortolotti D, Boujelbene N, Laaribi AB, Zidi N, Kehila M, Chelbi H, Boudabous A, Mrad K, Mezlini A, Di Luca D, Ouzari HI, Rizzo R, Zidi I.

Mol Immunol. 2018 Jul;99:82-86. doi: 10.1016/j.molimm.2018.04.007. Epub 2018 May 3.

PMID:
29730546
15.

Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T Cells.

Rothe K, Quandt D, Schubert K, Rossol M, Klingner M, Jasinski-Bergner S, Scholz R, Seliger B, Pierer M, Baerwald C, Wagner U.

Arthritis Rheumatol. 2016 Feb;68(2):337-46. doi: 10.1002/art.39331.

16.

High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseases.

Claus R, Bittorf T, Walzel H, Brock J, Uhde R, Meiske D, Schulz U, Hobusch D, Schumacher K, Witt M, Bartel F, Hausmann S.

Cell Immunol. 2000 Dec 15;206(2):85-100.

PMID:
11161440
17.

Soluble HLA in saliva of patients with autoimmune rheumatic diseases.

Adamashvili I, Pressly T, Gebel H, Milford E, Wolf R, Mancini M, Sittg K, Ghali GE, Hall V, McDonald JC.

Rheumatol Int. 2002 Jun;22(2):71-6. Epub 2002 May 4.

PMID:
12070679
18.

The plasma levels of soluble HLA-G molecules correlate directly with CD34+ cell concentration and HLA-G 14bp insertion/insertion polymorphism in cord blood donors.

Capittini C, Bergamaschi P, Sachetto S, Truglio M, Viola M, Marchesi A, Genovese V, Romano B, Guarene M, Poma R, Martinetti M, Tinelli C, Salvaneschi L.

Blood Transfus. 2014 Jan;12 Suppl 1:s361-6. doi: 10.2450/2012.0144-12. Epub 2013 Jan 23.

19.

Human leukocyte antigen (HLA)-G during pregnancy part II: associations between maternal and fetal HLA-G genotypes and soluble HLA-G.

Dahl M, Klitkou L, Christiansen OB, Djurisic S, Piosik ZM, Skovbo P, Møller AM, Steffensen R, Hviid TV.

Hum Immunol. 2015 Apr;76(4):260-71. doi: 10.1016/j.humimm.2015.01.015. Epub 2015 Jan 28.

PMID:
25637667
20.

The long-term immunosuppressive effects of disulfide-linked HLA-G dimer in mice with collagen-induced arthritis.

Kuroki K, Hirose K, Okabe Y, Fukunaga Y, Takahashi A, Shiroishi M, Kajikawa M, Tabata S, Nakamura S, Takai T, Koyanagi S, Ohdo S, Maenaka K.

Hum Immunol. 2013 Apr;74(4):433-8. doi: 10.1016/j.humimm.2012.11.060. Epub 2012 Dec 29.

Supplemental Content

Support Center